Al Hail Moza, Elkassem Wessam, Hamad Anas, Abdulrouf Pallivalappila, Thomas Binny, Stewart Derek
Hamad Medical Corporation, 3050, Doha, Qatar.
Robert Gordon University, Aberdeen, UK.
Int J Clin Pharm. 2018 Aug;40(4):769-774. doi: 10.1007/s11096-018-0629-5. Epub 2018 Apr 3.
Adverse Drug Reactions (ADRs) are major global concern, adversely impacting patient safety and health outcomes. ADRs cause significant morbidity and mortality among hospitalised patients, causing greater length of hospital stay, increased healthcare costs and patient dissatisfaction to the treatments. Pharmacovigilance (PV), a process of detecting, monitoring and preventing drug-related harm, plays a vital role to ensure patient safety. ADR reporting is the cornerstone of PV. PV practices in Qatar are relatively new and are evolving rapidly. The purpose of this article is to explore the medication safety practices (notably ADR reporting) at the largest academic healthcare center in Qatar. The article further provides evidence on how information related to ADRs are generated and interpreted. Furthermore, it describes how a designated center for monitoring medication safety activities was established at the largest healthcare provider in Qatar.
药品不良反应（ADR）是全球主要关注的问题，对患者安全和健康结果产生不利影响。ADR在住院患者中导致显著的发病率和死亡率，导致住院时间延长、医疗费用增加以及患者对治疗的不满。药物警戒（PV）作为一种检测、监测和预防药物相关伤害的过程，在确保患者安全方面发挥着至关重要的作用。ADR报告是药物警戒的基石。卡塔尔的药物警戒实践相对较新且发展迅速。本文的目的是探讨卡塔尔最大的学术医疗中心的用药安全实践（尤其是ADR报告）。本文还提供了有关ADR相关信息如何生成和解读的证据。此外，它描述了卡塔尔最大的医疗服务提供商如何设立一个专门的中心来监测用药安全活动。
